The following article, which first saw the light of day in May 2014, is an example of why there can more to a story than ...

The following article, which first appeared in The Post-Journal in May 2014, is an example of why there can more to a story ...

A family is preparing for three fundraising challenges in memory of their husband and dad who received treatment at an Oxford hospital.

"Woman," "elderly," and "disabled" were among a list of banned words reportedly circulating within the FDA, which the White ...

Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.

The approval was based on a comprehensive clinical data package, which included a single phase 1 trial and a phase 3 trial.

Shannin Desroches fought for a diagnosis after being dismissed. Now she tells PEOPLE that she's been given a 5% chance of ...

Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab biosimilar candidate (Stoboclo and Osenvelt) and its aflibercept biosimilar ...

The Metropolitan Opera will double cast a portion of Verdi and Puccini revivals and shift some contemporary compositions away ...

The FDA approved the denosumab biosimilar Ospomyv, interchangeable with Prolia, for preventing osteoporosis-related fracture ...

Dr. Greg Vigna Debridement for decubitus ulcers must align with treatment goals, with early reconstructive surgery recommended to avoid ris ...